Indications, complications, and outcomes following surgical management of locally advanced and metastatic renal cell carcinoma

Javier González, Jeffrey Gaynor, Mahmoud Alameddine, Manuel Esteban, Gaetano Ciancio

Research output: Contribution to journalReview article

3 Scopus citations


Introduction: Surgery may set the basis for a potential cure or would provide the best achievable quality of life in locally advanced or metastatic renal cell carcinoma (mRCC). However, survival extension with this approach would be scarce and not exempt from adverse events, thus preventing its recommendation in an already frail patient. An evidence based analysis on the role of surgery in each of the possible clinical scenarios involved under this heading may provide a clear picture on this issue and would be of value in the decision making process. Areas covered: Current literature was queried in PubMed/Medline in a systematic fashion. Manuscripts included were selected according to the quality of the data provided. A narrative review strategy was adopted to summarize the evidence acquired. Expert commentary: A surgery-based multimodal treatment approach should be strongly considered after adequate counseling in locally advanced and mRCC, since it may provide for additional benefits in terms of survival. However, a critical reevaluation of its adequacy, optimal timing, and selection of ideal candidates is currently ongoing.

Original languageEnglish (US)
Pages (from-to)237-250
Number of pages14
JournalExpert Review of Anticancer Therapy
Issue number3
StatePublished - Mar 4 2018



  • cytoreductive nephrectomy
  • indication
  • lymphadenectomy
  • metastasis
  • outcome
  • postoperative complication
  • Renal cell carcinoma
  • surgery
  • tumor thrombus

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Cite this